Skip Navigation

Reporting Guidelines

This website presents the first look at our ESG reporting, which will continue to expand and improve in the future. We have referenced several guidelines and accounting standards to collect information and will continuously expand monitoring and reporting to more activities that have a direct impact on sustainability factors.  

Among the guidelines we reference are the NASDAQ ESG reporting guide, where we currently cover a majority of the 33 core ESG metrics.  We have taken into consideration the Global Reporting Initiative (GRI) standards, UN Global Compact’s principles, the UN’s Sustainable Development Goals (SDGs) and Sustainable Accounting Standard Board’s guidelines.

Presenting this information reflects our firm commitment to conduct our activities in a financially, environmentally, and socially responsible way. As we progress our ESG initiatives, investors and other stakeholders will be provided with transparent information tracking our past performance, progress towards set goals and strategic initiatives to meet these objectives.

General Disclaimer

Goals and targets described in this ESG Portal or other Alvotech communications regarding ESG metrics are aspirational and not guarantees or promises that the goals or targets will be met. Numbers and percentages in this report include estimates or approximations and may be based on assumptions or incomplete data. We believe that the estimates employed are appropriate and reasonable; however, due to inherent uncertainties in making estimates and assumptions, actual results could differ from the original estimates. The inclusion of information contained in this disclosure should not be construed as a characterization regarding the materiality or financial impact of that information. Any references to websites outside of our ESG Portal, including third-party websites and other pages on Alvotech’s website, are provided for convenience only and the content of such websites are not incorporated by reference into the ESG Portal, nor do they constitute a part of the ESG Portal.

Forward-Looking Statements

Certain statements contained in this ESG Portal or in other Alvotech communications regarding ESG metrics may be considered “forward-looking statements.” Forward-looking statements generally relate to future events or the future financial operating performance of Alvotech and may include, for example, Alvotech’s expectations regarding our future corporate sustainability actions and performance on environmental, social and corporate governance topics, stakeholder engagement, its reporting on ESG indicators, the results of its enhanced governance framework, sustainability of its business, competitive advantages, business prospects and opportunities including pipeline product development, future plans and intentions, results, level of activities, performance, goals or achievements or other future events, the potential approval and commercial launch of its product candidates, regulatory approvals and market launches, and the estimated size of the total addressable market of Alvotech’s pipeline products. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by Alvotech and its management, are inherently uncertain and are inherently subject to risks, variability, and contingencies, many of which are beyond Alvotech’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) limited or incomplete data regarding performance under ESG metrics; (2) the outcome of any legal proceedings that may be instituted against Alvotech or others following the business combination between Alvotech Holdings S.A., Oaktree Acquisition Corp. II and Alvotech, with Alvotech as the surviving company; (3) the ability to maintain stock exchange listing standards;  (4) changes in applicable laws or regulations; (5) the possibility that Alvotech may be adversely affected by other economic, business, and/or competitive factors; (6) Alvotech’s estimates of expenses and profitability; (7) Alvotech’s ability to develop, manufacture and commercialize the product candidates in its pipeline; (8) actions of regulatory authorities, which may affect the initiation, timing and progress of clinical studies or future regulatory approvals or marketing authorizations; (9) the ability of Alvotech or its partners to enroll and retain patients in clinical studies; (10) the ability of Alvotech or its partners to gain approval from regulators for planned clinical studies, study plans or sites; (11) the ability of Alvotech’s partners to conduct, supervise and monitor existing and potential future clinical studies, which may impact development timelines and plans; (12) Alvotech’s ability to obtain and maintain regulatory approval or authorizations of its product candidates, including the timing or likelihood of expansion into additional markets or geographies; (13) the success of Alvotech’s current and future collaborations, joint ventures, partnerships or licensing arrangements; (14) Alvotech’s ability, and that of its commercial partners, to execute their commercialization strategy for approved products; (15) Alvotech’s ability to manufacture sufficient commercial supply of its approved products; (16) the outcome of ongoing and future litigation regarding Alvotech’s products and product candidates; (17) the potential impact of the ongoing COVID-19 pandemic on the FDA’s review timelines, including its ability to complete timely inspection of manufacturing sites; and (18) other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” that Alvotech may from time to time file or furnish with the SEC. There may be additional risks that Alvotech does not presently know or that Alvotech currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. Nothing in this portal  should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Alvotech does not undertake any duty to update these forward-looking statements or to inform the recipient of any matters of which any of them becomes aware of which may affect any matter referred to in this portal.